LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

LLY

965.93

+4.72%↑

JNJ

187.89

+0.86%↑

UNH

321.52

-0.8%↓

NVS

127.05

+0.61%↑

ABT

125.76

-0.34%↓

McKesson Corp

Затворен

СекторЗдравеопазване

858.45 0.88

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

840

Максимум

861.51

Ключови измерители

By Trading Economics

Приходи

-522M

784M

Продажби

7B

98B

P/E

Средно за сектора

32.891

77.256

Дивидентна доходност

0.35

Марж на печалбата

0.801

Служители

43,000

EBITDA

-454M

1.3B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+6.23% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.35%

2.33%

Следваща дата на дивидент

2.01.2026 г.

Следваща дата на екс-дивидент

1.12.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

13B

102B

Предишно отваряне

857.57

Предишно затваряне

858.45

Настроения в новините

By Acuity

37%

63%

124 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.11.2025 г., 22:17 ч. UTC

Печалби

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure -- Update

10.11.2025 г., 21:48 ч. UTC

Печалби

Commonwealth Bank Posts Flat 1Q Profit Despite Margin Pressure

10.11.2025 г., 23:44 ч. UTC

Пазарно говорене

Gold Edges Higher on Signs of Possible End to U.S. Govt Shutdown -- Market Talk

10.11.2025 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen, Earnings Hopes -- Market Talk

10.11.2025 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10.11.2025 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Basic Materials Roundup: Market Talk

10.11.2025 г., 21:50 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

10.11.2025 г., 21:49 ч. UTC

Придобивния, сливания и поглъщания

Paramount Stock Climbs as Forecast Beats Estimates -- Barrons.com

10.11.2025 г., 21:45 ч. UTC

Печалби

PepsiCo and 3 Other Defensive Stocks to Ride Out a Vulnerable Market -- Barrons.com

10.11.2025 г., 21:40 ч. UTC

Печалби

Friedman Industries 2Q EPS 32c >FRD

10.11.2025 г., 21:18 ч. UTC

Печалби

Occidental Petroleum 3Q Adj EPS 64c >OXY

10.11.2025 г., 21:17 ч. UTC

Печалби

Occidental Petroleum 3Q EPS 65c >OXY

10.11.2025 г., 21:17 ч. UTC

Печалби

Occidental Petroleum 3Q Rev $6.72B >OXY

10.11.2025 г., 21:16 ч. UTC

Печалби

Occidental Petroleum 3Q EPS 65c >OXY

10.11.2025 г., 21:16 ч. UTC

Печалби

Occidental Petroleum 3Q Adj EPS 64c >OXY

10.11.2025 г., 20:30 ч. UTC

Пазарно говорене

Expected End to U.S. Government Shutdown Helps Lift Crude -- Market Talk

10.11.2025 г., 20:24 ч. UTC

Пазарно говорене

Hopes For New Government Data Lift Gold -- Market Talk

10.11.2025 г., 20:08 ч. UTC

Пазарно говорене

U.S. Natural Gas Settles Higher As Colder Weather Arrives -- Market Talk

10.11.2025 г., 19:49 ч. UTC

Пазарно говорене

Mexican Industrial Production Seen Soft in September -- Market Talk

10.11.2025 г., 19:43 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Paramount Earnings Come Amid Warner Bros Merger Reports -- Barrons.com

10.11.2025 г., 19:16 ч. UTC

Печалби

Charles Schwab's CEO Is Worried About Prediction Markets. What He Told Thousands of Financial Advisors. -- Barrons.com

10.11.2025 г., 17:58 ч. UTC

Придобивния, сливания и поглъщания

Eli Lilly Stock on Pace for a New High. The Zepbound Maker Just Got a Big Upgrade. -- Barrons.com

10.11.2025 г., 17:56 ч. UTC

Пазарно говорене

Oil Futures Edge Up in Rangebound Trade -- Market Talk

10.11.2025 г., 17:32 ч. UTC

Печалби

Barrick Looking to Reset Safety Culture Following Fatalities -- Interview

10.11.2025 г., 17:30 ч. UTC

Печалби

Barrick Continues Efforts to Free Workers Jailed in Mali -- Interview

10.11.2025 г., 17:20 ч. UTC

Пазарно говорене
Печалби

Basic Materials Roundup: Market Talk

10.11.2025 г., 17:20 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

10.11.2025 г., 17:00 ч. UTC

Печалби

Barrick Looks to Get Handle On North American Operations, Find Growth -- Interview

10.11.2025 г., 17:00 ч. UTC

Печалби

Barrick Expects Strong Cash Flows Ahead With Commodity Prices at Current Levels, CFO Says in Interview

10.11.2025 г., 17:00 ч. UTC

Печалби

Barrick Conducting Bottom-Up Review of Nevada Ops, Looking for Growth Opportunities

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

6.23% нагоре

12-месечна прогноза

Среден 905.08 USD  6.23%

Висок 1,000 USD

Нисък 775 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

15 ratings

13

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

124 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat